You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


AlzeCure gets new Alzheimer’s abstract accepted

AlzeCure has announced that an abstract on NeuroRestore ACD856 – and its potential disease-modifying properties – has been accepted for presentation at the annual Clinical Trials in Alzheimer’s Conference, which is being held in San Francisco later this year.